DK1313481T3 - Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser - Google Patents
Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelserInfo
- Publication number
- DK1313481T3 DK1313481T3 DK01954214T DK01954214T DK1313481T3 DK 1313481 T3 DK1313481 T3 DK 1313481T3 DK 01954214 T DK01954214 T DK 01954214T DK 01954214 T DK01954214 T DK 01954214T DK 1313481 T3 DK1313481 T3 DK 1313481T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- indole compounds
- condensed indole
- condensed
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0019524A GB0019524D0 (en) | 2000-08-08 | 2000-08-08 | Novel use |
GB0118919A GB0118919D0 (en) | 2001-08-02 | 2001-08-02 | Novel use |
GB0119022A GB0119022D0 (en) | 2001-08-03 | 2001-08-03 | Novel use |
PCT/GB2001/003544 WO2002011766A2 (en) | 2000-08-07 | 2001-08-07 | Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
PCT/GB2001/003590 WO2002011733A1 (en) | 2000-08-08 | 2001-08-08 | Pharmaceutical composition comprising condensed indole compound |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1313481T3 true DK1313481T3 (da) | 2008-01-28 |
Family
ID=27447871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01954214T DK1313481T3 (da) | 2000-08-08 | 2001-08-08 | Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1313481B1 (da) |
JP (1) | JP2004505920A (da) |
AU (2) | AU7655801A (da) |
CA (1) | CA2418921C (da) |
DE (1) | DE60130667T2 (da) |
DK (1) | DK1313481T3 (da) |
ES (1) | ES2294012T3 (da) |
WO (1) | WO2002011733A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1476136E (pt) * | 2002-02-14 | 2006-10-31 | Glaxo Group Ltd | Composicao farmaceutica compreendendo n-((1-n-butil-4-piperidinil)metil)-3,4-di-hidro-2h-(1,3) oxazino (3,2-a) indole-10-carboxamida ou sal e processo de a obter compreendendo granulacao a seco. |
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
FR3097215B1 (fr) | 2019-06-13 | 2021-06-11 | Sodimas | Installation d’ascenseur |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3332830A1 (de) * | 1982-09-16 | 1984-03-22 | The Upjohn Co., 49001 Kalamazoo, Mich. | Verwendung von benzodiazepinen zur bekaempfung oder bei der behandlung von panikzustaenden |
ES2219813T3 (es) * | 1992-03-12 | 2004-12-01 | Smithkline Beecham Plc | N-(1-nbutil-4-piperidinil)metil-3,4-dihidro-2h-1,3-oxazino-3,2-a-indol-10-carboxamida, o una de sus sales farmaceuticamente aceptables. |
-
2001
- 2001-08-08 DE DE60130667T patent/DE60130667T2/de not_active Expired - Lifetime
- 2001-08-08 DK DK01954214T patent/DK1313481T3/da active
- 2001-08-08 ES ES01954214T patent/ES2294012T3/es not_active Expired - Lifetime
- 2001-08-08 AU AU7655801A patent/AU7655801A/xx active Pending
- 2001-08-08 CA CA2418921A patent/CA2418921C/en not_active Expired - Fee Related
- 2001-08-08 WO PCT/GB2001/003590 patent/WO2002011733A1/en active IP Right Grant
- 2001-08-08 EP EP01954214A patent/EP1313481B1/en not_active Expired - Lifetime
- 2001-08-08 AU AU2001276558A patent/AU2001276558B2/en not_active Ceased
- 2001-08-08 JP JP2002517069A patent/JP2004505920A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2418921A1 (en) | 2002-02-14 |
EP1313481B1 (en) | 2007-09-26 |
EP1313481A1 (en) | 2003-05-28 |
AU7655801A (en) | 2002-02-18 |
DE60130667T2 (de) | 2008-07-17 |
ES2294012T3 (es) | 2008-04-01 |
CA2418921C (en) | 2010-10-26 |
AU2001276558B2 (en) | 2005-11-24 |
DE60130667D1 (de) | 2007-11-08 |
WO2002011733A1 (en) | 2002-02-14 |
JP2004505920A (ja) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITTO20000779A0 (it) | Composizioni farmaceutiche. | |
ITTO20010005A0 (it) | Formulazione farmaceutica. | |
DK1397364T3 (da) | Hidtil ukendte pyrrolderivater som farmaceutiske midler | |
NO20025450L (no) | Ny farmasöytisk sammensetning | |
DK1524266T3 (da) | Farmaceutisk sammensætning | |
TR200003788A3 (tr) | Yavas salimli oral dozaj bilesim. | |
AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
FI20011478A (fi) | Farmaseuttinen koostumus | |
ITMI20010748A0 (it) | Composizioni farmaceutiche | |
MXPA03001425A (es) | Compuestos farmaceuticos. | |
DK1309317T3 (da) | Farmaceutiske præparater, der omfatter amlodipinmaleat | |
NO20032142D0 (no) | Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister | |
DK1248784T3 (da) | Kondenserede azepiner som vasopressinagonister | |
DK1339685T3 (da) | Biphenylcarboxamider, der er egnede som lipidsænkende midler | |
NO20026123L (no) | Farmasöytiske sammensetninger | |
NO20032614L (no) | Farmasöytisk sammensetning som har forbedret absorberbarhet | |
IT1311921B1 (it) | Composti farmaceutici. | |
AR028248A1 (es) | Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol | |
NO20031095D0 (no) | Farmasöytiske sammensetninger | |
ITMI20011637A0 (it) | Composizione farmaceutica contenente citalopram | |
DK1313481T3 (da) | Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser | |
NO20033073D0 (no) | Farmasöytisk sammensetning inneholdende citalopram | |
MXPA03001857A (es) | Composicones medicinales. | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
EE200200689A (et) | Ravimkoostised |